Osteoporotic Conditions Influence the Activity of Adipose-Derived Stem Cells

  • PDF / 1,573,457 Bytes
  • 11 Pages / 595.276 x 790.866 pts Page_size
  • 20 Downloads / 173 Views

DOWNLOAD

REPORT


Online ISSN 2212-5469

ORIGINAL ARTICLE

Osteoporotic Conditions Influence the Activity of Adipose-Derived Stem Cells Jeong Seop Park1 • Jiyuan Piao2 • Gabee Park2 • Kyung Sang Yoo2 Hyun Sook Hong1,3,4



Received: 19 June 2020 / Revised: 16 July 2020 / Accepted: 21 July 2020 Ó The Korean Tissue Engineering and Regenerative Medicine Society 2020

Abstract BACKGROUND: Estrogen deficiency decreases bone density and increases the risk of osteoporosis and fracture, thereby necessitating reconstruction of bone regeneration. As bone marrow mesenchymal stem cell (BMSCs) lose viability and differentiation potential under osteoporotic conditions, it is impossible to use autologous BMSCs for osteoporosis treatment. As an alternative, adipose-derived stem cells (ADSCs) may serve as the source of therapeutic cells. METHOD: We evaluated the effects of osteoporosis on the functional characteristics of ADSCs. Osteoporosis was induced in ovariectomy (OVX) rat model, and the ADSCs from Sham and OVX groups were cultured and analyzed comparatively. RESULTS: As a result, the viability was higher for the ADSCs from Sham group than those from OVX group. The analysis of the paracrine potential of ADSCs revealed the elevated levels of inflammatory and cellular senescence factors in the ADSCs from OVX group. The ADSCs from OVX group had much higher differentiation potential into adipocytes than those from the Sham group. Osteoporotic environment had no effect on the osteogenic potential of ADSCs. CONCLUSION: Osteoporosis may reduce the activity and influence immune response of ADSCs by modulating paracrine action and adipogenic potential. These characteristics of ADSCs should be given consideration for therapeutic purpose. Keywords Adipose-derived stem cell  Osteoporosis  Differentiation  Paracrine action

Electronic supplementary material The online version of this article (https://doi.org/10.1007/s13770-020-00289-x) contains supplementary material, which is available to authorized users. 3

East–West Medical Research Institute, Kyung Hee University Hospital, 26 Kyungheedae-ro, Dongdaemun-gu, Seoul 02447, Republic of Korea

4

Kyung Hee Institute of Regenerative Medicine (KIRM), Medical Science Research Institute, Kyung Hee University Medical Center, 26 Kyungheedae-ro, Dongdaemun-gu, Seoul 02447, Republic of Korea

& Hyun Sook Hong [email protected] 1

Department of Biomedical Science and Technology, Graduate School, Kyung Hee University, 26 Kyungheedaero, Dongdaemun-gu, Seoul 02447, Republic of Korea

2

Department of Genetic Engineering, College of Life Science and Graduate School of Biotechnology, Kyung Hee University, 1732 Deogyeong-daero, Giheung-gu, Yongin-si, Gyeonggi-do 17104, Republic of Korea

123

Tissue Eng Regen Med

1 Introduction Osteoporosis is an autoimmune disorder accompanied with the failure of hormonal regulation. This metabolic skeletal disease is characterized with the deterioration of the microstructure and a chronic decrease in the bone mass, leading to the risk of fracture. Women are much more likely to suffe